Observational Study of Elizaria® in aHUS Patients
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Atypical Hemolytic Uremic Syndrome
Sponsor: AO GENERIUM
This observational or N/A phase trial investigates Atypical Hemolytic Uremic Syndrome and aHUS and is currently completed. AO GENERIUM leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2021 — Sep 2022 [monthly]
Recruiting
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AO GENERIUM
For direct contact, visit the study record on ClinicalTrials.gov .